CRISPR is a revolutionary technology in genetic engineering, allowing scientists to edit genes with extreme precision. It has shown promise in treating many diseases, including cancer.
Bone cancer is a heterogeneous group of tumors that can be benign or malignant. Malignant bone cancers, which arise from bone or cartilage, account for approximately 0.2% of malignant tumors. They can be classified into different types, such as osteosarcoma, chondrosarcoma, and Ewing sarcoma, which differ primarily in their histological structure and age of onset.
A medical journal published by the I.D. Institute for Stem Cell and Genome Research
A medical journal published by the I.D. Institute for Stem Cell and Genome Research
I.D. Educational Community
Join the I.D. Community, an interactive environment bringing together experts, alumni, and students. This community aims to:
Exchange Clinical Expertise: Discuss challenging medical cases to enhance treatment outcomes.
Discuss Cutting-edge Research: Explore contemporary debates such as Digital Twins, Gerontology, and AI in medicine.
Build Professional Networks: Connect with leaders in regenerative medicine and global health organizations.
I.D. Educational Community
Join the I.D. Community, an interactive environment bringing together experts, alumni, and students. This community aims to:
Exchange Clinical Expertise: Discuss challenging medical cases to enhance treatment outcomes.
Discuss Cutting-edge Research: Explore contemporary debates such as Digital Twins, Gerontology, and AI in medicine.
Build Professional Networks: Connect with leaders in regenerative medicine and global health organizations.
